Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,631 | 260 | 57.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,520 | 2 | 40.2% |
| Travel and Lodging | $114.49 | 1 | 1.8% |
| Education | $5.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $3,191 | 40 | $0 (2024) |
| PFIZER INC. | $346.44 | 46 | $0 (2019) |
| ABBVIE INC. | $271.03 | 14 | $0 (2024) |
| Indivior Inc. | $263.27 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $201.78 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $193.38 | 12 | $0 (2019) |
| Amgen Inc. | $159.58 | 11 | $0 (2019) |
| Novo Nordisk Inc | $152.33 | 13 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $90.66 | 4 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $87.60 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $398.75 | 21 | Indivior Inc. ($97.94) |
| 2023 | $307.86 | 16 | ABBVIE INC. ($90.62) |
| 2022 | $366.15 | 21 | Alkermes, Inc. ($121.80) |
| 2021 | $225.05 | 21 | Alkermes, Inc. ($137.86) |
| 2020 | $12.91 | 1 | US WorldMeds, LLC ($12.91) |
| 2019 | $309.01 | 22 | Indivior Inc. ($53.22) |
| 2018 | $950.39 | 75 | PFIZER INC. ($184.80) |
| 2017 | $3,701 | 87 | Alkermes, Inc. ($2,735) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Opioid Use Disorder | ||||||
| 11/18/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: OUD | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Neuropsychiatry | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Neuropsychiatry | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: CNS | ||||||
| 08/26/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: OUD | ||||||
| 08/15/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Opioid Use Disorder | ||||||
| 07/29/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: OUD | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Neuropsychiatry | ||||||
| 04/09/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: CNS | ||||||
| 03/01/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: OUD | ||||||
| 03/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: OUD | ||||||
| 01/30/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: CNS | ||||||
| 01/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: CNS | ||||||
| 09/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 154 | $23,895 | $9,149 |
| 2022 | 2 | 36 | 195 | $28,099 | $11,142 |
| 2021 | 3 | 53 | 212 | $31,706 | $14,529 |
| 2020 | 4 | 73 | 244 | $33,352 | $12,840 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 69 | $12,420 | $5,289 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 85 | $11,475 | $3,860 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 131 | $16,789 | $6,257 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 64 | $11,310 | $4,884 | 43.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 114 | $19,722 | $8,619 | 43.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 76 | $9,044 | $4,564 | 50.5% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 12 | 22 | $2,940 | $1,346 | 45.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 95 | $16,435 | $6,575 | 40.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 103 | $12,257 | $4,684 | 38.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 12 | 26 | $2,960 | $1,346 | 45.5% |
| 80305 | Testing for presence of drug | Office | 2020 | 12 | 20 | $1,700 | $236.41 | 13.9% |
About Dr. Mina Kalfas, M.D
Dr. Mina Kalfas, M.D is a Addiction Medicine healthcare provider based in Covington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508808361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mina Kalfas, M.D has received a total of $6,271 in payments from pharmaceutical and medical device companies, with $398.75 received in 2024. These payments were reported across 264 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($3,631).
As a Medicare-enrolled provider, Kalfas has provided services to 191 Medicare beneficiaries, totaling 805 services with total Medicare billing of $47,659. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Addiction Medicine
- Other Specialties Family Medicine
- Location Covington, KY
- Active Since 06/13/2006
- Last Updated 11/21/2023
- Taxonomy Code 207QA0401X
- Entity Type Individual
- NPI Number 1508808361
Products in Payments
- Vivitrol 380 mg (Drug) $2,747
- VIVITROL (Drug) $372.23
- SUBLOCADE (Drug) $263.27
- VRAYLAR (Drug) $218.74
- CHANTIX (Drug) $161.79
- FARXIGA (Drug) $147.76
- JARDIANCE (Drug) $139.71
- CAPLYTA (Drug) $114.61
- Victoza (Drug) $112.13
- Prolia (Biological) $111.97
- HETLIOZ (Drug) $90.66
- LYRICA (Drug) $89.59
- Vivitrol (Drug) $71.42
- VIAGRA (Drug) $67.95
- Nuedexta (Drug) $64.76
- XARELTO (Drug) $63.85
- Amitiza (Drug) $63.82
- Livalo (Drug) $58.81
- INGREZZA (Drug) $57.36
- Movantik (Drug) $54.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction Medicine Doctors in Covington
Rachael Murphy, M.d, M.D
Addiction Medicine — Payments: $116,985
Dr. Teresa Koeller, M.d, M.D
Addiction Medicine — Payments: $3,686
Christina Wise, M.d, M.D
Addiction Medicine — Payments: $2,359
Chad Trosclair, Md, MD
Addiction Medicine — Payments: $418.44